Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 4/2009

01-04-2009 | Review

Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis

Authors: Jing Jiyong, Huang Tiancha, Cui Wei, Shen Huahao

Published in: Intensive Care Medicine | Issue 4/2009

Login to get access

Abstract

Objective

To evaluate the accuracy of the soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic test for bacterial infection.

Design

Meta-analysis of 13 diagnostic studies.

Data source

Medline; Embase; Web of Science (from January 1966 to January, update to August 2008); and Cochrane Controlled Clinical Trials Register Database (through first quarter 2008).

Measurements and results

A meta-analysis of all 73 studies was performed. Thirteen studies fulfilled the inclusion criteria (980 patients, 557 patients with bacterial infection, 423 with non-bacterial infection); global prevalence was 56.8%. The global sensitivity was 0.82 (95% confidence interval CI, 0.68–0.90), the specificity was 0.86 (95% CI, 0.77–0.91), the positive likelihood ratio (PLR) was 5.66 (95% CI, 3.41–9.38), the negative likelihood ratio (NLR) was 0.21 (95% CI, 0.12–0.40), and the diagnostic odds ratio (DOR) was 26.35 (95% CI, 10.32–67.28). The area under the curve of the summary receiver operator characteristic (SROC) was 0.86 (95% CI, 0.77–0.91), with a Q point value of 0.84. The sensitivity of the sTREM-1 assay for diagnosis of urinary tract infection was low (0.18, 95% CI, 0.05–0.51).

Conclusions

sTREM-1 represents a reliable biological marker of bacterial infection, but it may be not a sufficient biological marker for infection of the urinary tract as a result of its low sensitivity. Whether sTREM-1 guidance can reduce antibiotic use as well as the measurement of sTREM-1 in different types of infection will require additional prospective studies.
Literature
1.
Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138–150PubMedCrossRef
2.
Davis BH (2005) Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn 5:193–207PubMedCrossRef
3.
Brun-Buisson C (2000) The epidemiology of the systemic inflammatory response. Intensive Care Med 26(Suppl 1):S64–S74PubMedCrossRef
4.
American College of Chest Physicians, Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef
5.
Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474PubMedCrossRef
6.
Reinhart K, Meisner M, Brunkhorst FM (2006) Markers for sepsis diagnosis: what is useful? Crit Care Clin 22:503–519, ix–x
7.
Ramirez P, Menendez R, Torres A (2007) New biological markers of ventilator-associated pneumonia. Clin Pulm Med 14:93–98CrossRef
8.
Gibot S, Kolopp-Sarda MN, Bene MC, Cravoisy A, Levy B, Faure GC, Bollaert PE (2004) Summaries for patients. A possible new test for diagnosing sepsis. Ann Intern Med 141:146
9.
Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA (2007) Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 50:34–41PubMedCrossRef
10.
Tang BM, Eslick GD, Craig JC, McLean AS (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7:210–217PubMedCrossRef
11.
Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217PubMedCrossRef
12.
Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164:4991–4995PubMed
13.
14.
Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL (2003) A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 170:3812–3818PubMed
15.
Bouchon A, Facchetti F, Weigand MA, Colonna M (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410:1103–1107PubMedCrossRef
16.
Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, Bezemer PD (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9PubMedCrossRef
17.
Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3:25PubMedCrossRef
18.
Sackett D, Haynes R (2002) The architecture of diagnostic research. Br Med J 324(7336):539–541CrossRef
19.
20.
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629–634
21.
Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463PubMedCrossRef
22.
Tejera A, Santolaria F, Diez ML, Aleman-Valls MR, Gonzalez-Reimers E, Martinez-Riera A, Milena-Abril A (2007) Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 38:117–123PubMedCrossRef
23.
Horonenko G, Hoyt JC, Robbins RA, Singarajah CU, Umar A, Pattengill J, Hayden JM (2007) Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 132:58–63PubMedCrossRef
24.
Gibot S, Cravoisy A, Dupays R, Barraud D, Nace L, Levy B, Bollaert PE (2007) Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis 39:604–608PubMedCrossRef
25.
Liu CL, Hsieh WY, Wu CL, Kuo HT, Lu YT (2007) Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Respir Med 101:903–909PubMedCrossRef
26.
Phua J, Koay ESC, Zhang D, Tal LK, Boo XL, Lim KC, Lim TK (2006) Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections. Eur Respir J 28:695–702PubMedCrossRef
27.
Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L, Buonsanti C, Colonna M, Sinigaglia F, Panina-Bordignon P, Fabbri LM (2004) Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 24:247–250PubMedCrossRef
28.
29.
El Solh AA, Akinnusi ME, Peter M, Berim I, Schultz MJ, Pineda L (2008) Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes. Intensive Care Med 34:1012–1019PubMedCrossRef
30.
Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE (2004) Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350:451–458PubMedCrossRef
31.
Gibot S, Kolopp-Sarda MN, Bene MC, Cravoisy A, Levy B, Faure GC, Bollaert PE (2004) Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141:9–15PubMed
32.
Determann RM, Millo JL, Gibot S, Korevaar JC, Vroom MB, van der Poll T, Garrard CS, Schultz MJ (2005) Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 31:1495–1500PubMedCrossRef
33.
Determann RM, Weisfelt M, de Gans J, van der Ende A, Schultz MJ, van de Beek D (2006) Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med 32:1243–1247PubMedCrossRef
34.
Bishara J, Hadari N, Shalita-Chesner M, Samra Z, Ofir O, Paul M, Peled N, Pitlik S, Molad Y (2007) Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults. Eur J Clin Microbiol Infect Dis 26:647–650PubMedCrossRef
35.
Chan MC, Chang KM, Chao WC, Lin LY, Kuo BI, Hsu JY, Wu CL (2007) Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology 12:333–338PubMedCrossRef
36.
Determann RM, Schultz MJ, Geerlings SE (2007) Soluble triggering receptor expressed on myeloid cells-1 is not a sufficient biological marker for infection of the urinary tract. J Infect 54:e249–e250PubMedCrossRef
37.
Kim JH, Park EY, Kim WH, Park W, Jeong HC, Lee JH, Kim EK (2007) Soluble triggering receptor expressed on myeloid cells-1: role in the diagnosis of pleural effusions. Tuberc Respir Dis 62:290–298CrossRef
38.
Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11:R38PubMedCrossRef
39.
Yun SS, Jin HL, Eun MC, Jung HC (2007) Diagnostic utility of pleural fluid soluble triggering receptor expressed on myeloid cells 1 protein in patients with exudative pleural effusion. Tuberc Respir Dis 62:499–505
40.
Chen HL, Hung CH, Tseng HI, Yang RC (2008) Soluble form of triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of serious bacterial infection in febrile infants less than three months of age. Jpn J Infect Dis 61:31–35PubMed
41.
Huh JW, Lim CM, Koh Y, Oh YM, Shim TS, Lee SD, Kim WS, Kim DS, Kim WD, Hong SB (2008) Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in BAL fluid from patients with bilateral lung infiltrates. Crit Care 12:R6PubMedCrossRef
42.
Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, Mosteller F (1994) Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120:667–676PubMed
43.
Deeks JJ (2001) Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. Br Med J 323:157–162CrossRef
44.
Wong-Baeza I, Gonzalez-Roldan N, Ferat-Osorio E, Esquivel-Callejas N, Aduna-Vicente R, Arriaga-Pizano L, Astudillo-de la Vega H, Villasis-Keever MA, Torres-Gonzalez R, Estrada-Garcia I, Lopez-Macias C, Isibasi A (2006) Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol 145:448–455PubMedCrossRef
45.
46.
Irwig L, Macaskill P, Glasziou P, Fahey M (1995) Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol 48:119–130 Discussion 131–132PubMedCrossRef
47.
Stuck AE, Rubenstein LZ, Wieland D (1998) Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. Br Med J 316:469 Author reply 470–461
48.
Vandenbroucke JP (1998) Bias in meta-analysis detected by a simple, graphical test. Experts’ views are still needed. Br Med J 316:469–470 Author reply 470–471
49.
Song F, Eastwood AJ, Gilbody S, Duley L, Sutton AJ (2000) Publication and related biases. Health Technol Assess 4:1–115
Metadata
Title
Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis
Authors
Jing Jiyong
Huang Tiancha
Cui Wei
Shen Huahao
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 4/2009
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-008-1333-z

Other articles of this Issue 4/2009

Intensive Care Medicine 4/2009 Go to the issue

Original

Is helmet CPAP first line pre-hospital treatment of presumed severe acute pulmonary edema?

Original

Increased circulating regulatory T cells (CD4+CD25+CD127−) contribute to lymphocyte anergy in septic shock patients

Brief Report

Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?

Erratum

On track to limit antifungal overuse!

Correspondence

Let automated weaning systems rise to the Summit. Response to the letter of Maldonado et al.

Editorial

On track to limit antifungal overuse!